Irish chemical industry news

• 10 October 2024

  CycleØ Group to invest €100m in four biomethane plants in Ireland

  The investment will support decarbonization, waste management, and create green jobs, with no financial risk for farmers, using innovative nitrogen stripping technology.
• 

  7 October 2024

  PCI Pharma invests $365M in EU and US facilities for advanced drug delivery and device products

  Investments enhance drug-device assembly, packaging, and storage in the US and EU, focusing on injectables and biologics, with new facilities in Illinois and Ireland.
• 

  21 September 2024

  Lilly Invests $1.8 Billion in Irish Manufacturing Expansion

  The $1.8B investment will boost production of Alzheimer's, diabetes, and obesity treatments, create 150 jobs, and enhance sustainability with advanced technologies and a solar farm.
• 

  11 September 2024

  Ashland Expands Viatel™ Bioresorbable Polymers Facility in Ireland

  The expansion enhances capabilities and headcount, supporting innovative bioresorbable polymer technology. Backed by IDA Ireland, it underscores commitment to life sciences and local talent.
• 

  9 July 2024

  Heygaz Biomethane to Acquire Ormonde Organics

  The acquisition includes two anaerobic digestion plants and a planned third facility. The current management will stay. The deal awaits Irish regulatory approval.
• 

  13 December 2023

  Arkema to Acquire Arc Building Products in Ireland

  The acquisition will enhance Arkema's market position in Ireland, expanding its product range and local production. The deal is set to close in Q1 2024.

• 

  23 August 2022

  MSD Ireland Expands Carlow Site

  Over 100 new jobs will be created as a new facility for next-gen oncology biologics begins construction, operational by 2025, adding to the existing 530 staff and 700 construction roles.
• 

  12 August 2022

  Abbott Invests €430 Million in Irish Diabetes Operations

  New greenfield facility in Kilkenny and expansion in Donegal will create 1,000 jobs, supported by the Irish Government through IDA Ireland.
• 

  23 May 2022

  Merck Invests €440 Million to Expand Manufacturing in Cork, Ireland

  The investment will boost membrane and filtration manufacturing, create 370 jobs by 2027, and support novel therapies, vaccines, and diagnostics, aligning with sustainability goals.
• 

  8 March 2022

  DuPont Invests Millions to Upgrade Athlone Facility

  The investment will enhance MABR production, train staff, and support regional growth, backed by the Irish Government and IDA Ireland.
• 

  22 November 2019

  WuXi Vaccines to Invest $240M in New Ireland Facility

  The new facility in Dundalk will create 200 jobs, produce vaccines for a global pharma, and enhance Ireland's life sciences ecosystem, pending planning approval.
• 

  8 January 2019

  Almac Group Adopts Continuous Flow Technology

  The company expands its API services with continuous flow technology, enhancing product quality, process safety, and efficiency. A 4-year strategy focuses on advanced synthesis methods.
• 

  5 July 2018

  Praxair to Sell European Assets to Taiyo Nippon Sanso

  The sale, worth 5 billion euros, includes Praxair's industrial gases businesses in 12 countries and 2,500 employees. The deal is contingent on the Praxair-Linde merger and regulatory approvals.
• 

  31 May 2017

  Takeda to Build New Production Facility in Ireland

  The new facility will expand Takeda's Grange Castle site, creating 40 jobs and producing NINLARO® for global markets. Construction starts June 2017, with operations beginning in late 2018.
• 

  11 January 2017

  Boliden Expands Tara Mine

  New mineralisation at Tara zinc mine identified. Tailings dam expansion and exploration drift approved, extending mine life to 2026. Investment totals EUR 44m, pending permits.
• 

  5 December 2016

  Takeda to Invest €40M in New Dublin Facility

  The €40M investment will expand the Grange Castle site, creating 40 jobs and producing the oncology product NINLARO™. Supported by IDA Ireland, it highlights confidence in Ireland's pharma sector.
• 

  20 September 2016

  Evonik Invests in Vivasure Medical

  Evonik's investment supports Vivasure's bioabsorbable arteriotomy closure device, leveraging Evonik's polymer expertise to enhance minimally invasive procedures and patient outcomes.
• 

  2 August 2016

  Jazz Pharmaceuticals Opens New Facility in Roscommon

  The new facility, supported by IDA Ireland, represents a €50 million investment and will employ up to 50 people. It has received FDA and Irish regulatory approval.
• 

  26 February 2016

  GSK Opens Two New Facilities After €12m Cork Investment

  The new Kilo Scale Facility and Technical Development Laboratory will enhance manufacturing of oncology medicines and improve existing products, reinforcing the Cork site's technical capabilities.
• 

  12 September 2014

  BASF Expands Cork Manufacturing Plant

  The Cork site will boost LIX® solvent extractant production by Q1 2015 to meet rising demand. New labs in Johannesburg, Shanghai, and Moscow enhance technical service and customer proximity.
• 

  10 February 2014

  Jazz Pharmaceuticals Begins Construction on New Facility in Ireland

  The new facility in Roscommon will cost $60-$68M, create 160 construction jobs, and 50 permanent jobs. Supported by IDA Ireland, it marks Jazz's first manufacturing site. Completion expected in 2016.
• 

  28 March 2013

  UC RUSAL to Convert Aughinish Refinery to Gas

  The Aughinish refinery in Ireland will replace oil-fired boilers with gas-powered steam generators by 2014, enhancing economic and environmental performance amid a broader modernization effort.
• 

  29 March 2007

  GSK to Invest €250M in Irish Facility

  The investment will support production of lapatinib for advanced breast cancer treatment, creating up to 150 new jobs at the Currabinny site, established in 1975 and employing over 600 people.